Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mariangela Pasqualoni
Observed names:
M. Pasqualoni,
Pasqualoni, Mariangela
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-5492-8371
Observed ORCID:
0000-0001-5492-8371
OpenAlex ID:
A5068813830
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer
2018
·
Ida Paris
, Stefano Cianci
, et al.
·
International Journal of Hyperthermia
·
33
PDF
Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response
2023
·
Mariangela Pasqualoni
, Armando Orlandi
, et al.
·
Frontiers in Oncology
·
22
PDF
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
2023
·
Luca Mastrantoni
, Giovanna Garufi
, et al.
·
Therapeutic Advances in Medical Oncology
·
12
PDF
Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
2021
·
Armando Orlandi
, Letizia Pontolillo
, et al.
·
Journal of Personalized Medicine
·
11
PDF
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
2023
·
Ernesto Rossi
, Giovanni Schinzari
, et al.
·
Biomedicines
·
7
PDF
Scalp Cooling in Preventing Chemotherapy-Induced Alopecia for Early Breast Cancer Patients: Long-Term Outcomes of Real- Life Data
2024
·
Mariangela Pasqualoni
, Laura Orlando
, et al.
·
Research Square
254P Development of machine learning models for the prediction of early progression (EP) to first-line (1L) cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) therapy in oestrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC)
2024
·
S. Pannunzio
, L. Mastrantoni
, et al.
·
ESMO Open
3171: Breast Cancer Radiotherapy after Neoadjuvant Systemic Therapy: a retrospective evaluation
2024
·
Marzia borgia
, Maria Chiara De Luca
, et al.
·
Radiotherapy and Oncology
Abstract P2-02-06: Adjuvant Denosumab treatment in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
2023
·
Luca Mastrantoni
, Giovanna Garufi
, et al.
·
Cancer Research
1592P Cardiovascular toxicity in patients treated with a PARP inhibitor for solid tumors: A meta-analysis
2022
·
M.C. Cannizzaro
, C. Ciccarese
, et al.
·
Annals of Oncology
PDF
Abstract P3-05-06: Impact on outcome and response to neoadiuvant chemotherapy in triple negative breast cancer patients and BRCA mutations
2020
·
Ida Paris
, Roberta Rizza
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
85
H-index:
5
I10-index:
4
Year
Topic
Type